Inconclusive St. John’s Wort Trial Prompts Queries On Study Design, Setting
This article was originally published in The Tan Sheet
Executive Summary
The inconclusive nature of a recent study on St. John's wort suggests the current procedure for funding and designing clinical trials of botanicals may need to be reexamined, according to a letter in the July 24 Journal of the American Medical Association
You may also be interested in...
Supplement Dose Escalation Trials Help Foster Success – NCCAM’s Berman
Initial dose escalation trials will improve the success rate of dietary supplement clinical trials, according to director of NCCAM's Office of Clinical & Regulatory Affairs, Jonathan Berman, MD, PhD
NIMH Phytoestrogen, Depression Studies Begin Initial Enrollment
Recruitment screening has begun for an NIH randomized, placebo-controlled clinical study on the effects of treatment with Novagen's Rimostil phytoestrogen supplement and raloxifene (Eli Lilly's Evista) on peri-menopausal depression
St. John’s Wort Multi-Center Trial In Mild Depression Underway
A multi-center clinical trial on St. John's wort in mild depression is underway with $4 mil. in funding from three National Institutes of Health divisions, according to the National Center for Complementary and Alternative Medicine